logo
Plus   Neg
Share
Email

GlaxoSmithKline Sells Two Travel Vaccines Rabipur And Encepur To Bavarian Nordic

GlaxoSmithKline plc (GSK,GSK.L) announced the sale of travel vaccines Rabipur for the prevention of rabies, and Encepur for the prevention of tick-borne encephalitis, to Bavarian Nordic. These brands were acquired from Novartis (NVS) in 2015 as part of the acquisition of its vaccines business.

GSK will receive an upfront payment of approximately EUR 301 million or £259 million and milestone payments for a total consideration of up to EUR 955 million or £822 million. The transaction is expected to close by the end of 2019.

GSK noted that both vaccines will continue to be manufactured primarily at Marburg site in Germany until full production is transferred to Bavarian Nordic. The staged technology transfer is expected to commence in the first quarter of 2020 with completion anticipated within 5 years.

Roger Connor, President, Global Vaccines at GSK, said, "This agreement with Bavarian Nordic will enable us to commit greater resources to our key growth assets and to our R&D pipeline, while also ensuring the continued supply of these important and successful vaccines."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Apple Inc. (AAPL) unveiled a 16-inch MacBook Pro laptop with a larger screen and redesigned keyboard. It is the first major update since the MacBook Pro line was revamped three years ago. The company has moved from a 15-inch screen to a higher-resolution 16-inch screen. Facebook has launched its new payment platform called 'Facebook Pay' in the U.S., joining other tech giants like Google and Apple that have their own payment platforms. The new service will be available across Facebook and its associated apps - Messenger, Instagram and WhatsApp, the social media giant said in a blog post. The payment service supports most major credit and debit cards. Amneal Pharmaceuticals, LLC recalled certain lots of heartburn medication Ranitidine in the form of tablets and syrup for the potential presence of nitrosamine impurity, N-Nitrosodimethylamine, above levels established by the U.S. Food and Drug Administration or FDA. The generic and specialty pharma company is recalling 94 lots of Ranitidine tablets and Syrup.
Follow RTT
>